UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D. C. 20549
                                   FORM 10-QSB


( X ) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
      EXCHANGE ACT OF 1934

      FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002
                                     -------------

(   ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
      EXCHANGE ACT OF 1934


             FOR THE TRANSITION PERIOD FROM __________ TO __________

                        COMMISSION FILE NUMBER 000-26119

                          ALTRIMEGA HEALTH CORPORATION
                          ----------------------------
               (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)

                   NEVADA                                   87-0631750
-----------------------------------------------   -----------------------------
      (STATE OR OTHER JURISDICTION OF                    (I.R.S. EMPLOYER
       INCORPORATION OR ORGANIZATION)                   IDENTIFICATION NO.)

5600 BELL STREET, SUITE 111, AMARILLO, TEXAS                   79106
-----------------------------------------------   -----------------------------
  (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)                  (ZIP CODE)


                                 (806) 331-6398
                                 --------------
               REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE

(FORMER  NAME,  FORMER  ADDRESS,  AND FORMER  FISCAL YEAR, IF CHANGED SINCE LAST
REPORT.)

INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS REQUIRED
TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DURING
THE  PRECEDING 12 MONTHS (OR FOR SUCH  SHORTER  PERIOD THAT THE  REGISTRANT  WAS
REQUIRED  TO FILE SUCH  REPORTS),  YES [X ] NO [ ], AND (2) HAS BEEN  SUBJECT TO
SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS. YES [X ] NO [ ]

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

INDICATE THE NUMBER OF SHARES  OUTSTANDING  OF EACH OF THE  ISSUER'S  CLASSES OF
COMMON STOCK, AS OF THE LAST PRACTICABLE DATE.

              CLASS                     OUTSTANDING AS OF JUNE 30, 2002
              -----                     -------------------------------
       COMMON STOCK, $0.001                       22,020,000

                                       1
<PAGE>

                                     PART I
                              FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

The accompanying  balance sheets of Altrimega Health  Corporation (a development
stage  company)  at June  30,  2002  and  December  31,  2001,  and the  related
statements of operations  and cash flows for the three and six months ended June
30, 2002 and 2001 and the period from  September 8, 1998 to June 30, 2002,  have
been  prepared  by  the  Company's  management  in  conformity  with  accounting
principles generally accepted in the United States of America. In the opinion of
management,  all adjustments considered necessary for a fair presentation of the
results of  operations  and  financial  position have been included and all such
adjustments are of a normal recurring nature.

Operating  results  for the quarter  ended June 30,  2002,  are not  necessarily
indicative of the results that can be expected for the year ending  December 31,
2002.

                                       2
<PAGE>

                          ALTRIMEGA HEALTH CORPORATION
                           (DEVELOPMENT STAGE COMPANY)
                                 BALANCE SHEETS
                       JUNE 30, 2002 AND DECEMBER 31, 2001
--------------------------------------------------------------------------------


                                               JUN 30,           DEC 31,
                                                2002              2001
                                            ------------      -------------

ASSETS
CURRENT ASSETS
  Cash                                       $       -         $      -
                                            ------------      -------------
    Total Current Assets                     $       -         $      -
                                            ============      =============

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Accounts payable                           $   32,219        $      -
                                            ------------      -------------
    Total Current Liabilities                    32,219               -
                                            ------------      -------------
STOCKHOLDERS' EQUITY
  Preferred stock
    10,000,000 shares authorized at
    $0.001 par value; none outstanding               -                -
  Common stock
    50,000,000 shares authorized at
    $0.001 par value; 22,020,000 shares
    issued and outstanding                       22,020           22,020
  Capital in excess of par value                117,135          117,135

  Deficit accumulated during the
    development stage                          (171,374)        (139,155)
                                            ------------      -------------
    Total Stockholders' Deficiency              (32,219)              -
                                            ------------      -------------
                                              $      -         $      -
                                            ============      =============


   The accompanying notes are an integral part of these financial statements.

                                       3
<PAGE>

                          ALTRIMEGA HEALTH CORPORATION
                           (DEVELOPMENT STAGE COMPANY)
                            STATEMENTS OF OPERATIONS
                FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2002
                 AND 2001 AND THE PERIOD SEPTEMBER 8, 1998 (DATE
                         OF INCEPTION) TO JUNE 30, 2002
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                        THREE MONTHS                     SIX MONTHS
                                  -----------------------        ------------------------
<S>                              <C>          <C>              <C>           <C>            <C>
                                                                                             SEPT 8, 1998
                                    JUN 30,      JUN 30,           JUN 30,       JUN 30,        TO JUN 30,
                                     2002         2001              2002          2001             2002
                                  ----------   ----------        ----------   -----------     -------------
REVENUES                           $      -     $      -          $      -      $      -        $   9,703
                                  ----------   ----------        ----------   -----------     -------------

EXPENSES
  Product development                     -            -                 -             -           76,692
  Administrative                     21,324        1,750            32,219        12,830          103,091
  Depreciation                            -            -                 -             -            1,294
                                  ----------   ----------        ----------   -----------     -------------
                                     21,324        1,750            32,219        12,830          181,077
                                  ----------   ----------        ----------   -----------     -------------

NET LOSS                           $(21,324)    $ (1,750)         $(32,219)     $(12,830)       $(171,374)
                                  ==========   ==========        ==========   ===========     =============
NET LOSS PER COMMON SHARE
  Basic                            $      -     $      -          $      -      $      -
                                  ----------   ----------        ----------   -----------     -------------

AVERAGE OUTSTANDING SHARES
  Basic (stated in 1,000's)          22,020       22,020            22,020        22,020
                                  -----------  ----------        ----------   -----------     -------------

</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                       4
<PAGE>

<TABLE>
<CAPTION>
                          ALTRIMEGA HEALTH CORPORATION
                           (DEVELOPMENT STAGE COMPANY)
                             STATEMENT OF CASH FLOWS
                 FOR THE SIX MONTHS ENDED JUNE 30, 2002 AND 2001
                    AND THE PERIOD SEPTEMBER 8, 1998 (DATE OF
                           INCEPTION) TO JUNE 30, 2002
--------------------------------------------------------------------------------
<S>                                            <C>             <C>              <C>
                                                  JUN 30,          JUN 30,       SEPT 8, 1998 TO
                                                   2002              2001         JUN 30, 2002
                                                ----------       -----------     ----------------
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                     $  (32,219)       $  (12,830)       $  (171,374)
  Adjustments to reconcile net loss to net
    cash provided by operating activities
  Depreciation                                          -               280                  -
    Changes in accounts payable                    32,219            32,566             69,882
    Contributions to capital - expenses                 -                 -              4,492
                                               -----------       -----------       ------------
     Net Cash Received (Used) in Operations             -            20,016            (97,000)
                                               -----------       -----------       ------------

CASH FLOWS FROM INVESTING ACTIVITIES
  Advance deposit - lease                               -           (20,000)                 -
                                               -----------       -----------       ------------

CASH FLOWS FROM FINANCING ACTIVITIES
    Proceeds from issuance of common stock              -                 -             97,000
                                               -----------       -----------       ------------
    Net Increase (decrease)  in Cash                    -                16                  -
    Cash at Beginning of Period                         -                33                  -
                                               -----------       -----------       ------------
    Cash at End of Period                      $        -        $       49        $         -
                                               ===========       ===========       ============
NON CASH FLOWS FROM OPERATING AND INVESTING
 ACTIVITIES
  Contributions to capital - expenses -
   related parties - 2001                      $    4,492
                                               ----------
  Contributions to capital - forgiveness
   of debt - related party - 2001                  37,663
                                               ----------
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       5
<PAGE>

                          ALTRIMEGA HEALTH CORPORATION
                           (DEVELOPMENT STAGE COMPANY)
                          NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

1.  ORGANIZATION

The Company was incorporated  under the laws of the State of Nevada on September
8, 1998 with the name of Mega  International  Health Corporation with authorized
common stock of 50,000,000 shares with a par value of $0.001 and preferred stock
of  10,000,000  shares with a par value of $0.001.  The board of directors  will
determine  the powers and rights of the  preferred  stock when it is issued.  On
June 23, 1999 the name was changed to Altrimega Health Corporation.  The Company
was organized for the purpose of marketing nutritional products.

The Company is in the development stage.

On March 5, 2001 the Company  completed a forward stock split of four shares for
each outstanding  share. This report has been prepared showing after stock split
shares from inception.

2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

ACCOUNTING METHODS
------------------

The  Company  recognizes  income and  expenses  based on the  accrual  method of
accounting.

DIVIDEND POLICY
---------------

The Company has not adopted a policy regarding payment of dividends.

INCOME TAXES
------------

On June 30, 2002 the Company had a net operating loss  carryforward of $171,374.
The tax benefit of  approximately  $51,412 from the loss carry  forward has been
fully offset by a valuation reserve because the use of the future tax benefit is
doubtful,  since the Company has no  operations  on which to project  future net
profits. The loss carryover will expire in 2023.

BASIC AND DILUTED NET INCOME (LOSS) PER SHARE
---------------------------------------------

Basic net income  (loss) per share  amounts are  computed  based on the weighted
average  number of shares  actually  outstanding.  Diluted net income (loss) per
share amounts are computed  using the weighted  average  number of common shares
and common  equivalent  shares  outstanding  as if shares had been issued on the
exercise of the preferred share rights unless the exercise becomes  antidilutive
and then only the basic per share amounts are shown in the report.

                                        6
<PAGE>

2.   SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

FINANCIAL INSTRUMENTS
---------------------

The carrying amounts of financial  instruments,  including accounts payable, are
considered by management to be their estimated fair values.

ESTIMATES AND ASSUMPTIONS
-------------------------

Management uses estimates and assumptions in preparing  financial  statements in
accordance with accounting principles generally accepted in the United States of
America.  Those  estimates and  assumptions  affect the reported  amounts of the
assets and liabilities, the disclosure of contingent assets and liabilities, and
the reported revenues and expenses. Actual results could vary from the estimates
that were assumed in preparing these financial statements.

OTHER RECENT ACCOUNTING PRONOUNCEMENTS
--------------------------------------

The  Company  does not  expect  that the  adoption  of other  recent  accounting
pronouncements to have any material impact on its financial statements.

3.  SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES

Officers-directors  of the Company have acquired 28% of the  outstanding  common
stock.

A  former  president-director  has made a  contribution  to the  capital  by the
forgiveness of debt due him from the Company of $37,663.

Former  officers-directors have made contributions to the capital of the Company
by the payment of expenses incurred by the Company of $4,492.

4.  GOING CONCERN

The Company will need additional working capital to service its debt and for its
future planned  activity and  continuation  of the Company as a going concern is
dependent upon  obtaining  sufficient  working  capital to be successful in that
effort and the  management  of the  Company has  developed a strategy,  which it
believes will accomplish this objective through  additional equity funding,  and
long term  financing,  which will  enable the  Company to operate for the coming
year.

                                       7
<PAGE>

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

Altrimega  Health  Corporation was  incorporated  under the laws of the State of
Nevada on  September  8, 1998 as Mega Health  Corporation.  On June 23, 1999 the
name of the Corporation was changed to Altrimega Health Corporation.

Our  initial  plan of  operation  focused on  marketing  natural  medicines  and
nutritional  supplements.  We attempted to establish a distribution network with
various  marketing firms with experience in marketing  nutritional  supplements,
however, these marketing efforts proved unsuccessful.

We began seeking potential business  acquisition or opportunities to enter in an
effort to continue business operations. In July 2001, we entered into a Plan and
Agreement  of Merger to  acquire  all of the issued  and  outstanding  shares of
YellowOnline.com,  a California corporation.  The transaction  contemplated that
upon closing,  both the common and preferred  shareholders  of  YellowOnline.com
would together own no less than 84% of our then issued and  outstanding  shares.
This transaction was not completed and was terminated on November 1, 2001.

On November 9, 2001, our president and  controlling  shareholder,  Howard Abrams
sold 13,200,000 shares of our common stock owned by him to Rio Investment Group,
LLC, a Delaware limited liability  company.  The 13,200,000  shares  represented
approximately 59.9% of our issued and outstanding shares. In connection with the
transaction,  Abrams resigned as an officer and director and Ashley Choate,  Ft.
Worth, Texas, was appointed to replace him.

On December  11,  2001,  Altrimega  Health  Corporation,  a Nevada  corporation,
entered into an Exchange  Agreement with Advanced  Messaging  Wireless,  Inc., a
Texas  corporation.  Pursuant to the Exchange  Agreement,  the  shareholders  of
Advanced  were to  exchange  all of the  outstanding  shares of common  stock of
Advanced  Messaging  for an  aggregate  of  10,000,000  shares of common  stock.
Pursuant to the  proposed  transaction,  Advanced  was to become a wholly  owned
subsidiary of Altrimega.  On July 15, 2002,  Altrimega  terminated  the Exchange
Agreement with Advanced due to its failure to satisfy its conditions subsequent.

On July 25, 2002,  Altrimega  entered into a  non-binding  letter of intent with
Creative Holdings, Inc., a South Carolina corporation. Pursuant to the Letter of
Intent  and upon the  consummation  of a  definitive  agreement,  Atrimega  will
acquire Creative  Holdings.  Upon consummation of the merger,  Creative Holdings
will become a wholly owned subsidiary of Altrimega.  At closing,  Altrimega will
issue 20,000,000  shares of common stock to the former  shareholders of Creative
Holdings.  Further,  Altrimega  is  obligated  to seek  shareholder  approval to
increase its  authorized  capital stock to  800,000,000  shares of common stock.
Upon obtaining such approval, Altrimega will be obligated to issue an additional
300,000,000  shares of  common  stock to the  former  shareholders  of  Creative
Holdings,  such that they will own a total of 320,000,000 shares of common stock
upon completion of the transaction.

Creative  Holdings is a real estate holding company.  Creative Holdings holds an
option to purchase a 49%  interest in a joint  venture  project in North  Myrtle
Beach,  South  Carolina  known as the Barefoot  Resort and Golf  Community.  The
project is under  development and contemplates a yacht marina with 167 slips and
a multi-use  building for retain and residential units. The project will require
additional funding to complete.

RESULTS OF OPERATIONS
---------------------

We are a  development  stage  company  and had  limited  operations  during  the
three-month  period  ended  June  30,  2002,  wherein  we  incurred  $21,324  in
administrative  expenses.  Since our  inception on  September  8, 1998,  we have
generated  net losses of  $171,374,  based on limited  operating  capital.  As a
result,  the report of our auditor at December 31, 2001 contains a going concern
modification as to our ability to continue as a going concern.  Our continuation
as a going  concern is  dependent  on our  ability to meet our  obligations  and
obtain  additional  debt or equity  financing  required  until we  complete  the
proposed  merger with  Creative  Holdings  and are able to obtain  profitability
through our  operations.  Until such time, we have taken the following  steps to
revise our  operating and  financial  requirements  in an effort to enable us to
continue in existence:

    o   We have reduced  administrative  expenses to a minimum by  consolidating
management responsibilities to our chief executive officer.

    o   We will seek,  if required,  either  equity or further debt funding from
principal shareholders.

                                       8
<PAGE>

    o   We will  attempt to obtain the  professional  services of  third-parties
through  favorable  financing  arrangements  or payment by the  issuance  of our
common stock.

    o   We believe that the foregoing plan will enable us to generate sufficient
funds to continue its operations for the next twelve months.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

Altrimega had no cash or assets as of June 30, 2002. Altrimega is dependent upon
its ability to consummate the transaction with Creative  Holdings and thereafter
to raise capital from the sale of debt or equity  securities.  Such capital will
be  required  in order for  Altrimega  to  continue  operations,  which  consist
primarily  of its  need to pay  administrative  expenses  until  the  merger  of
Creative  Holdings is  consummated.  Altrimega has no commitments for financing.
Administrative  expenses are expected to consist  primarily of professional fees
necessary  to file  its  periodic  reports  with  the  Securities  and  Exchange
Commission,  including  the  review  and  audit  of  its  financial  statements.
Altrimega has minimized its expenses as discussed  above.  Upon  consummation of
the acquisition of Creative  Holdings,  Altrimega  anticipates that its need for
capital will also include  helping to fund the  Barefoot  Resort joint  venture.
Creative  Holdings owns a 49% interest in Barefoot Resort.  No assurances can be
given that the  acquisition of Creative  Holdings will be  consummated  due to a
number  of  factors,   including  the  finalization  of  definitive  agreements,
shareholder approval for an increase in Altrimega's authorized capital stock and
approval of the acquisition by the shareholders of Creative Holdings.

CRITICAL ACCOUNTING POLICIES
----------------------------

Below is a summary of Altrimega's critical accounting policies.

      ACCOUNTING METHODS.  Altrimega recognizes income and expenses based on the
accrual method of accounting.

      DIVIDEND POLICY.  Altrimega has not adopted a policy regarding  payment of
dividends.

      INCOME  TAXES.  On June  30,  2002,  Altrimega  had a net  operating  loss
carryforward of $171,374. The tax benefit of approximately $51,412 from the loss
carry  forward has been fully offset by a valuation  reserve  because the use of
the future tax benefit is doubtful, since the Company has no operations on which
to project future net profits. The loss carryover will expire in 2023.

      BASIC AND DILUTED NET INCOME (LOSS) PER SHARE. Basic net income (loss) per
share  amounts  are  computed  based on the  weighted  average  number of shares
actually  outstanding.  Diluted net income (loss) per share amounts are computed
using the weighted average number of common shares and common  equivalent shares
outstanding as if shares had been issued on the exercise of the preferred  share
rights  unless the  exercise  becomes  antidilutive  and then only the basic per
share amounts are shown in the report.

      FINANCIAL  INSTRUMENTS.  The carrying  amounts of  financial  instruments,
including  accounts payable,  are considered by management to be their estimated
fair values.

      ESTIMATES AND  ASSUMPTIONS.  Management  uses estimates and assumptions in
preparing  financial   statements  in  accordance  with  accounting   principles
generally  accepted  in the  United  States  of  America.  Those  estimates  and
assumptions  affect the  reported  amounts of the  assets and  liabilities,  the
disclosure of contingent  assets and liabilities,  and the reported revenues and
expenses.  Actual  results  could vary from the  estimates  that were assumed in
preparing these financial statements.

                                       9
<PAGE>

PART II

OTHER INFORMATION
-----------------

ITEM 1.  LEGAL PROCEEDINGS.

         There is no pending litigation against us.

ITEM 2.  CHANGES IN SECURITIES AND USE OF PROCEEDS.

         (a), (b), (c) and (d)      None.


ITEM 3.  DEFAULTS UPON SENIOR SECURITIES.

         None.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

         None.

ITEM 5.  OTHER INFORMATION.

         Not applicable.

                                       10
<PAGE>

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.

         (A)      EXHIBITS.

<TABLE>
<CAPTION>
EXHIBIT
NO.       DESCRIPTION                                         LOCATION
-------   --------------------------------------------------  -------------------------------------------------
<S>       <C>                                                 <C>
2.1       Agreement  and Plan of Merger dated July 19, 2001,  Incorporated by reference to Exhibit 2.1 to the
          by  and  among   Altrimega   Health   Corporation,  Corporation's 8-K filed with the SEC on July 31,
          Altrimega Merger Sub, Inc. and YellowOnline.com     2001

2.2       Exchange   Agreement   between   Altrimega  Health  Incorporated by reference to Exhibit 2.01 to the
          Corporation and Advanced Messaging Wireless,  Inc.  Corporation's 8-K filed with the SEC on March
          dated December 11, 2001                             27, 2002

3.1       Articles of Incorporation                           Incorporated by reference to Exhibit 3.1.1 to
                                                              the Corporation's 10-SB filed with the SEC on
                                                              January 21, 2000

3.2       Amendment to Articles of Incorporation              Incorporated by reference to Exhibit 3.1.2 to
                                                              the Corporation's 10-SB filed with the SEC on
                                                              January 21, 2000

3.3       Certificate of Amendment to Articles of             Incorporated by reference to Exhibit A to the
          Incorporation                                       Corporation's PRE 14C filed on January 31, 2002

3.4       Bylaws                                              Incorporated by reference to Exhibit 3.2 to the
                                                              Corporation's 10-SB filed with the SEC on
                                                              January 21, 2000

10.1      Letter of Intent dated July 25, 2002, by and        Incorporated by reference to Exhibit 99.1 to the
          between Altrimega Health Corporation and Creative   Corporation's 8-K filed on July 26, 2002
          Holdings Inc.

</TABLE>

         (B)      REPORTS ON FORM 8-K.

         On July 19, 2002, Altrimega filed a Form 8-K announcing the termination
of the proposed acquisition of Advanced Messaging Wireless, Inc.

         On July 26, 2002,  Altrimega  filed a Form 8-K announcing the letter of
intent to acquire Creative Holdings, Inc.

                                       11
<PAGE>

                                   SIGNATURES

         In accordance with the requirements of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

Date:    August 14, 2002               ALTRIMEGA HEALTH CORPORATION

                                       By:  /s/ Kelley Magee
                                          -------------------------------
                                            Kelley Magee


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Altrimega Health Corporation
(on Form 10-QSB for the period ended June 30, 2002 as filed with the  Securities
and  Exchange  Commission  on  the  date  hereof  (the  "Report"),  each  of the
undersigned,  in the  capacities  and  on  the  dates  indicated  below,  hereby
certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that to his knowledge:

         1. The Report fully complies with the  requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The  information  contained in the Report  fairly  presents,  in all
material respects, the financial condition and results of operation of Altrimega
Health Corporation.


         August 14, 2002                 /s/ Kelley Magee
-------------------------------          --------------------------------------
Date                                     Kelley Magee
                                         President and Chief Executive Officer


         August 14, 2002                 /s/ Kelley Magee
-------------------------------          --------------------------------------
Date                                     Kelley Magee
                                         Chief Financial Officer

                                       12